Recently a new variant of Creutzfeldt-Jakob disease, a human prion disease, with prominent psychiatric manifestations in the early stage was identified, suggesting that human prion disease may be associated with mental disorders. Furthermore, a novel missense mutation with asparagine-to-serine substitution at codon 171 of the human prion gene (N171S) was identified in a family with severe psychiatric symptoms. This finding provides further clue that the prion gene may be a susceptibility gene for certain psychiatric disorders. We systematically sequenced the protein-coding and untranslated exons of prion gene in 62 Han Chinese schizophrenic patients with positive family history from Taiwan. We identified two polymorphisms that alter amino acid sequences, a methionine/valine at codon 129 (M129V) and a glutamate/lysine at codon 219 (E219K), respectively. Further comparison of the genotype, allele and haplotype frequency distributions of these two polymorphisms between 234 schizophrenic patients and 100 non-psychotic controls, however, did not reveal significant differences between two groups. Besides, no other mutations in the prion gene were identified in these 62 patients. Hence, our results suggest that the prion gene may not play a major role in conferring susceptibility to schizophrenia. Molecular Psychiatry (2001) 6, 74-78.
Introduction
Human prion disease is a progressive neurodegenerative disease characterized by spongiform pathology in the cerebral cortex. Human prion diseases include Kuru, Creutzfeld-Jakob disease (CJD), GerstmannStraeussler-Scheinker syndrome (GSS), and fatal familial insomnia (FFI). The disease has various presentations as hereditary, sporadic and infectious. GSS and FFI are familial diseases linked to mutations in the prion gene; kuru is an acquired disease by eating infected relatives in Papua New Guinea; while CJD has sporadic, familial and iatrogenically transmitted forms. 1, 2 Creutzfeld-Jakob disease is a relatively rare neurodegenerative disorder with a variable age of onset, the prevalence of CJD is approximately 1/1 000 000. Approximately 15% of the cases of CJD are inherited in an autosomal dominant fashion, whereas the majority of CJD cases arise as a sporadic illness. Only a small number of cases arise as a result of accidental inoculation with infectious prion protein. Neurological signs are common among CJD, including cerebellar ataxia, myoclonus, extrapyramidal features, cortical blindness and global dementia. 3, 4 Psychiatric manifestations such as depression and personality change are not uncommon in the early phase of CJD, 5, 6 suggesting a possible association of prion disease and human mental disorders. Recently, a new variant of CJD (nvCJD) has been reported. Patients with new variant CJD are younger at age of onset than CJD, and have prominent psychiatric features early in the illness. [7] [8] [9] These findings add further evidence to implicate a possible role of the prion gene in the pathogenesis of human mental disorders. In addition, Samaia et al 10 reported a novel missense mutation with asparagineto-serine alteration at codon 171 (N171S) of the prion gene in a three-generation family with psychiatric symptoms. In this family, several members were affected with severe psychiatric symptoms such as auditory hallucinations, persecutory delusion, and dementia. This mutation was found in five out of six family members with mental illness, while only one of six unaffected family members has this mutation. 10 The results suggest that prion gene mutations may account for part of the pathology of human psychiatric disorders.
These findings promoted us to study the possible involvement of the prion gene in schizophrenia in our population. To address this issue, we set out to perform sequence analysis of the human prion gene in a sample of Chinese schizophrenic patients with positive family history from Taiwan. The human prion protein is encoded by a single copy gene mapped to chromosome 20p. 11 The complete genomic DNA of the human prion gene comprises an untranslated exon 1 and a single protein-coding exon 3. An additional exon-like sequence analogous to exon 2 of the sheep and mouse prion gene was identified in the intron region of human prion genomic sequences. The exon 2-like sequence was flanked by consensus splice acceptor and donor sites, although it is apparently not translated. 12 In this study, all the exon 1, exon 2-like region, and exon 3 and their flanking intronic regions were sequenced. The study was carried out in two stages. At the first stage, 62 patients with positive family history were recruited for mutation analysis. At the second stage, a case-control association study was performed in an extended number of patients and controls using polymorphisms identified from the first stage.
Materials and methods

Subjects
All patients and controls were Han Chinese from Taiwan. Sixty-two unrelated schizophrenic patients with positive family history were recruited for direct sequencing study, while another 172 unrelated Han Chinese schizophrenic patients were recruited for association study. In total, there were 129 male and 105 female patients, the mean age 47 years old. All the patients were evaluated by two psychiatrists with consensus and met the DSM-IV diagnostic criteria for schizophrenia. One hundred non-psychotic adults were recruited as a comparison group, including 56 males and 44 females. The mean age was 45 years old. Informed consent was obtained from the subjects and genomic DNA was prepared from peripheral blood using standard methods.
PCR amplification and purification
The primer sets used for PCR amplification were designed using the Map function of SeqWeb (Genetics Computer Group, Madison, WI, USA). The M13 forward sequences (5Ј-cacgacgttgtaaaacgac-3Ј) or M13 Reverse sequences (5Ј-ggataacaatttcacacagg-3Ј) or T7 promoter sequences (5Ј-taatacgactcactataggg-3Ј) were linked to the PCR primer pairs for sequencing purpose. In general, 30 cycles of PCR amplification were performed and amplification conditions were optimized to produce a single amplicon. The sequences of the primers, length of PCR products, and optimal annealing temperature are listed in Table 1 . The standard ampli- . The PCR products were subjected to electrophoresis in agarose gel and purified from gel using QIAquick Gel Extraction Kit (Qiagen, Hilden, Germay).
PCR-based autosequencing
The purified PCR products were subjected to fluorescence-based autosequencing using LI-COR autosequencer (LI-COR, Lincoln, Nebraska, USA) according to the manufacturer's instructions. The infrared fluorescently labeled M13 forward, reverse primers and T7 primer from LI-COR were used as universal sequencing primers. PCR-based sequencing reactions were performed using AmpliCycle sequencing kit according to the protocol from the manufacturer (Perkin Elmer, Branchburg, NJ, USA).
PCR-based genotyping
The genotyping method of M129V essentially followed Palmer et al 13 with modification. In brief, 30 cycles of amplification were carried out at 94°C for 1 min; 60°C for 1 min; 72°C for 1 min, using standard PCR mixtures with sense primer (5Ј ttttgcagagcagtcattatg-3Ј) and antisense primer (5Ј-cgtgtgctgcttgattgtg-3Ј). Aliquots of PCR products (582 bp) were digested with Nsp1 overnight at 37°C incubation. After restriction digestion, the products were subjected to electrophoresis in 2% agarose gel. The Met (M) allele yields 405-bp, 102-bp and 75-bp fragments, while the Val (V) allele yields 480-bp and 102-bp fragments. The genotyping method for E219K essentially followed Furukawa et al 14 with modification. In brief, 30 cycles of PCR amplification were performed at 94°C for 1 min; 55°C for 1 min; 72°C for 1 min using standard PCR mixtures with a mismatched sense primer (5Ј-agcagatgtgtatcaccccgta-3Ј) and an antisense primer (5Ј-aggaagatgaggaaagagatc-3Ј). Aliquots of PCR products were digested with BsiW1 overnight at 55°C incubation. After restriction digestion, the products were subjected to electrophoresis in 3% agarose gel. The Glu (E) allele yielded PCR fragments of 98 and 20 bp, while the Lys (K) allele remained uncut, 118 bp. 
Statistics
Comparisons of the genotype, allele frequency and haplotype frequency distributions of the schizophrenic patients and comparison subjects were performed using chi-square tests. Multisite haplotype frequencies were estimated by using a computer program for population genetics, Arlequin. 15 The statistic analysis was implemented using the Linkage Utilities Programs. 16 
Results
The locations of the primer sets for PCR amplification of the human prion gene are illustrated in Figure 1 . Two polymorphisms were identified among these 62 schizophrenic patients. One is an A-to-G transition at the first nucleotide of codon 129, causing a methionine-to-valine substitution, designated M129V. The other polymorphism is a G-to-A transition at the first nucleotide of codon 219, resulting in a glutamate-tolysine substitution, designated E219K. The M129V polymorphism alters a Nsp1 restriction site, which facilitates the PCR-based genotyping. The E219K does not change restriction enzyme recognition site, hence, a mismatched sense primer was designed to create an artificial BsiW1 restriction site to facilitate the genotyping. We further determined the genotypes of these two polymorphisms among another 172 schizophrenic patients and 100 non-psychiatric controls, and compared their allele, genotype and haplotype distributions between these two groups. The results are illustrated in Tables 2 and 3 . No significant differences of genotype, allele, and estimated haplotype frequency distributions were observed between schizophrenic patients and controls in this sample. No further mutations were identified among these 62 schizophrenic patients after completely sequencing the whole three exons of the prion gene.
Discussion
Human prion disease is a unique entity of neurodegenerative disease. Although mainly characterized by the neurological deficits and demented symptoms, the psychiatric symptoms are not uncommon among patients with human prion-associated disease. It is reported that about one third of CJD patients manifested psychi- atric symptoms such as depression and personality change, and this may lead to erroneous psychiatric diagnoses. 6, [17] [18] [19] A series study reported that about 10% of the CJD patients were first admitted to psychiatric hospitals. 5 In Taiwan, Yen et al 20 reported five out of eight Taiwanese CJD patients had psychiatric symptoms including changes of mood, thought and perception. In fact, four of these five patients had even been treated under various psychiatric diagnoses. Currently, psychosis has been recognized as a common feature of neurodegenerative disease. Auditory hallucination, delusion and personality change may occur in a wide range of neurodegenerative diseases such as Alzheimer's dementia, Hungtington's disease, Parkinson's disease, diffuse Lewy body disease. 21 Hence, it is not unexpected to find psychiatric manifestations in patients with new variant CJD.
Several genetic aberrations of human prion gene have been identified, including insertion and deletion of octapeptide coding sequences within an octapeptide repeat region, missense and nonsense mutations in protein coding sequences. 22, 23 In this study, after complete sequencing of the human prion gene, we did not detect any genetic variants segregated with schizophrenia, nor did we identify the N171S mutation as reported by Samaia et al 10 in our patients. Our results are consistent with the report from Arnold et al, 24 who found no protease-resistant prion protein in postmortem frontal cortical and thalamic tissues from a wellcharacterized sample of elderly patients with chronic, sporadic, poor outcome schizophrenia. They argued against a role for abnormal prion proteins in the pathogenesis of schizophrenia.
The clinical symptoms of human prion disease are not only determined by the nature of mutation in the prion protein, but are also affected by the methionine/valine common polymorphism at codon 129 (M129V). It is observed that homozygosity of methionine at this position increases the susceptibility to both sporadic and iatrogenic CJD. 13, 25 The genotype of codon 129 also influences the clinical phenotype of the mutation at codon 178 (D178N). Methionine at codon 129 produces FFI, while valine at this site results in typical CJD. 26 In this study, however, we did not observe the influence of the M129V polymorphism on susceptibility to schizophrenia. The allele frequency of the K allele is 4% in our population, which is similar to that of 6% in Japanese. 27, 28 The K219 allele has not been detected in Europeans. 29 Like the Met129 allele that may influence the susceptibility to CJD, the K219 allele was also reported to delay the disease process of GSS and have protective effect against CJD in Japanese. 14, 28 In the present study, we still did not observe significant association of the E219K polymorphism with schizophrenia.
In summary, after complete sequencing of the three exons of the prion gene in a sample of schizophrenic patients, we did not identify mutations that may underlie the susceptibility to schizophrenia, nor did we find the N171S mutation reported by Samaia et al 10 in our patients. Although two polymorphisms were identified in this study, no associations with schizophrenia were identified. Hence, our data suggest that the human prion gene may not be a susceptibility gene for schizophrenia.
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